content: <PAGE>
  
  --------------------------------------------------------------------------------
  --------------------------------------------------------------------------------
  
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C.  20549
  
  
                                     Form 8-K
                                  CURRENT REPORT
  
                      PURSUANT TO SECTION 13 OR 15(d) OF THE
                          SECURITIES EXCHANGE ACT OF 1934
  
  
                                   June 13, 2001
                                  Date of Report
  
                                (Earliest Reported
                              Event is June 10, 2001)
  
                                REMEDY CORPORATION
              (Exact name of registrant as specified in its charter)
  
                           Commission File No. 000-25494
  
  
             Delaware                                  77-0265675
  (State or other jurisdiction of           (IRS Employer Identification No.)
  incorporation or jurisdiction)
  
  
        1585 Charleston Road                              94043
      Mountain View, California                         (Zip Code)
  (Address of principal executive offices)
  
  
  
        Registrant's telephone number, including area code: (650) 903-5200
  
  
  --------------------------------------------------------------------------------
          (Former names or former address, if changed since last report)
  --------------------------------------------------------------------------------
  <PAGE>
  
  Item 5.  OTHER EVENTS.
  
       On June 10, 2001, Peregrine Systems, Inc., a Delaware corporation
  ("Peregrine"), Rose Acquisition Corporation, a Delaware corporation and wholly-
  owned subsidiary of Peregrine, and Remedy Corporation, a Delaware corporation
  ("Remedy"), entered into an Agreement and Plan of Merger and Reorganization (the
  "Merger Agreement") providing for the business combination of Remedy and
  Peregrine through the merger of Remedy with and into Rose Acquisition
  Corporation, after which Rose Acquisition Corporation will be the surviving
  corporation (the "Merger"). Pursuant to the Merger Agreement, each share of
  common stock of Remedy issued and outstanding immediately prior to the effective
  time of the Merger will be converted into the right to receive $9.00 in cash and
   .9065 of a share of the common stock of Peregrine. Peregrine and Remedy issued a
  joint press release announcing the pending Merger on June 11, 2001.
  
       Consummation of the Merger is subject to certain conditions, including (i)
  approval of the transaction by the stockholders of Remedy and (ii) expiration or
  termination of the waiting period under the Hart-Scott-Rodino Antitrust
  Improvements Act of 1976, as amended.
  
       In connection with the Merger, certain stockholders of Remedy have entered
  into voting agreements, all dated as of June 10, 2001, pursuant to which those
  stockholders agree to vote in favor of adopting the Merger Agreement and
  approving the Merger.
  
       A copy of the Merger Agreement is attached hereto as Exhibit 2.1 and is
  incorporated by reference in its entirety. A copy of the form of Voting
  Agreement entered into between Peregrine and certain stockholders of Remedy is
  attached hereto as Exhibit 9.1 and is incorporated by reference in its entirety.
  A copy of the form of Affiliate Agreement entered into between Peregrine and
  certain stockholders is attached hereto as Exhibit 99.1 and is incorporated by
  reference in its entirety. A copy of the joint press release issued by Peregrine
  and Remedy on June 11, 2001, is attached hereto as Exhibit 99.2 and is
  incorporated by reference in its entirety.
  
  Item 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
  
  Exhibit No.    Description.
  -----------    ------------
  
      2.1        Agreement and Plan of Merger and Reorganization, dated as of June
                 10, 2001, by and among Peregrine, Rose Acquisition Corporation
                 and Remedy.
  
      9.1        Form of Voting Agreement between Peregrine and certain
                 stockholders of Remedy.
  
      99.1       Form of Affiliate Agreement between Peregrine and certain
                 stockholders of Remedy.
  
      99.2       Joint Press Release, dated June 11, 2001, by Peregrine and
                 Remedy.
  
  
  
  <PAGE>
  
                                    SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
  
  
  Date: June 13, 2001              Remedy Corporation
  
                                   By: /s/ Ron J. Fior
                                       -------------------------------------------
                                       Ron J. Fior, Vice President Finance &
                                       Operations, Chief Financial Officer
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "d8k.txt", "description": "FORM 8-K", "secsgml_size_bytes": 4877}]
metadata_filer: {"company-data": {"conformed-name": "REMEDY CORP", "cik": "0000936653", "assigned-sic": "7372", "irs-number": "770265675", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-25494", "film-number": "1659961"}, "business-address": {"street1": "1505 SALADO DR", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043", "phone": "4159035200"}, "mail-address": {"street1": "1505 SALADO DRIVE", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043"}}
text: --------------------------------------------------------------------------------
  --------------------------------------------------------------------------------
  
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C.  20549
  
                                     Form 8-K
                                  CURRENT REPORT
  
                      PURSUANT TO SECTION 13 OR 15(d) OF THE
                          SECURITIES EXCHANGE ACT OF 1934
  
                                   June 13, 2001
                                  Date of Report
  
                                (Earliest Reported
                              Event is June 10, 2001)
  
                                REMEDY CORPORATION
              (Exact name of registrant as specified in its charter)
  
                           Commission File No. 000-25494
  
             Delaware                                  77-0265675
  (State or other jurisdiction of           (IRS Employer Identification No.)
  incorporation or jurisdiction)
  
        1585 Charleston Road                              94043
      Mountain View, California                         (Zip Code)
  (Address of principal executive offices)
  
        Registrant's telephone number, including area code: (650) 903-5200
  
  --------------------------------------------------------------------------------
          (Former names or former address, if changed since last report)
  --------------------------------------------------------------------------------
  Item 5.  OTHER EVENTS.
  
       On June 10, 2001, Peregrine Systems, Inc., a Delaware corporation
  ("Peregrine"), Rose Acquisition Corporation, a Delaware corporation and wholly-
  owned subsidiary of Peregrine, and Remedy Corporation, a Delaware corporation
  ("Remedy"), entered into an Agreement and Plan of Merger and Reorganization (the
  "Merger Agreement") providing for the business combination of Remedy and
  Peregrine through the merger of Remedy with and into Rose Acquisition
  Corporation, after which Rose Acquisition Corporation will be the surviving
  corporation (the "Merger"). Pursuant to the Merger Agreement, each share of
  common stock of Remedy issued and outstanding immediately prior to the effective
  time of the Merger will be converted into the right to receive $9.00 in cash and
   .9065 of a share of the common stock of Peregrine. Peregrine and Remedy issued a
  joint press release announcing the pending Merger on June 11, 2001.
  
       Consummation of the Merger is subject to certain conditions, including (i)
  approval of the transaction by the stockholders of Remedy and (ii) expiration or
  termination of the waiting period under the Hart-Scott-Rodino Antitrust
  Improvements Act of 1976, as amended.
  
       In connection with the Merger, certain stockholders of Remedy have entered
  into voting agreements, all dated as of June 10, 2001, pursuant to which those
  stockholders agree to vote in favor of adopting the Merger Agreement and
  approving the Merger.
  
       A copy of the Merger Agreement is attached hereto as Exhibit 2.1 and is
  incorporated by reference in its entirety. A copy of the form of Voting
  Agreement entered into between Peregrine and certain stockholders of Remedy is
  attached hereto as Exhibit 9.1 and is incorporated by reference in its entirety.
  A copy of the form of Affiliate Agreement entered into between Peregrine and
  certain stockholders is attached hereto as Exhibit 99.1 and is incorporated by
  reference in its entirety. A copy of the joint press release issued by Peregrine
  and Remedy on June 11, 2001, is attached hereto as Exhibit 99.2 and is
  incorporated by reference in its entirety.
  
  Item 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
  
  Exhibit No.    Description.
  -----------    ------------
  
      2.1        Agreement and Plan of Merger and Reorganization, dated as of June
                 10, 2001, by and among Peregrine, Rose Acquisition Corporation
                 and Remedy.
  
      9.1        Form of Voting Agreement between Peregrine and certain
                 stockholders of Remedy.
  
      99.1       Form of Affiliate Agreement between Peregrine and certain
                 stockholders of Remedy.
  
      99.2       Joint Press Release, dated June 11, 2001, by Peregrine and
                 Remedy.
  SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
  Date: June 13, 2001              Remedy Corporation
  
                                   By: /s/ Ron J. Fior
                                       -------------------------------------------
                                       Ron J. Fior, Vice President Finance &
                                       Operations, Chief Financial Officer